⌘K

Login Start Free

Home/Filings/4/0000891293-15-000056

4//SEC Filing

CTI BIOPHARMA CORP 4

Accession 0000891293-15-000056

CIK 0000891293operating

View on SEC.gov Company Profile

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 5:49 PM ET

Size

17.4 KB

Accession

0000891293-15-000056

Insider Transaction Report

Form 4

Period: 2015-10-29

CTI BIOPHARMA CORPctic

EVP, Finance & Administration

Transactions

Sale
Common Stock
2015-10-29$1.38/sh−1,100$1,518→ 930,247 total
Sale
Common Stock
2015-10-29$1.43/sh−100$143→ 921,547 total
Sale
Common Stock
2015-10-29$1.39/sh−2,200$3,058→ 928,047 total
Sale
Common Stock
2015-10-29$1.40/sh−800$1,120→ 927,247 total
Sale
Common Stock
2015-10-29$1.40/sh−100$140→ 927,147 total
Sale
Common Stock
2015-10-29$1.41/sh−300$423→ 926,847 total
Sale
Common Stock
2015-10-29$1.42/sh−500$711→ 921,647 total
Sale
Common Stock
2015-10-29$1.43/sh−200$286→ 921,347 total
Sale
Common Stock
2015-10-29$1.42/sh−4,700$6,674→ 922,147 total

Holdings

Common Stock
(indirect: By Trust)
37

Footnotes (1)

[F1]The sale was effected pursuant to a Rule 10b5-1 trading plan.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

CTI BIOPHARMA CORP

CIK 0000891293

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000891293

Filing Metadata

Form type: 4
Filed: Oct 29, 8:00 PM ET
Accepted: Oct 30, 5:49 PM ET
Size: 17.4 KB

View on SEC.gov